K. Lien

Selective Inhibitor of JAK 1 , for the Preclinical Characterization of GLPG 0634 , a Feyen and

Vandeghinste, B. Smets, K. Conrath, 2013 .

Selegiline (1‐deprenyl) and low‐dose levodopa treatment of Parkinson's disease A double‐blind crossover trial.

J. Berstad, J. Presthus, K. Lien, 1987, Acta neurologica Scandinavica.